Your browser doesn't support javascript.
loading
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.
Salomé, Bérengère; Gomez-Cadena, Alejandra; Loyon, Romain; Suffiotti, Madeleine; Salvestrini, Valentina; Wyss, Tania; Vanoni, Giulia; Ruan, Dan Fu; Rossi, Marianna; Tozzo, Alessandra; Tentorio, Paolo; Bruni, Elena; Riether, Carsten; Jacobsen, Eva-Maria; Jandus, Peter; Conrad, Curdin; Hoenig, Manfred; Schulz, Ansgar; Michaud, Katarzyna; Della Porta, Matteo Giovanni; Salvatore, Silvia; Ho, Ping-Chih; Gfeller, David; Ochsenbein, Adrian; Mavilio, Domenico; Curti, Antonio; Marcenaro, Emanuela; Steinle, Alexander; Horowitz, Amir; Romero, Pedro; Trabanelli, Sara; Jandus, Camilla.
Afiliación
  • Salomé B; Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
  • Gomez-Cadena A; Department of Oncological Sciences, Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Loyon R; Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
  • Suffiotti M; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
  • Salvestrini V; Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
  • Wyss T; Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
  • Vanoni G; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
  • Ruan DF; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Rossi M; Department of Specialistic, Diagnostic and Experimental Medicine, Institute of Hematology "Seràgnoli," University Bologna, Bologna, Italy.
  • Tozzo A; Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
  • Tentorio P; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
  • Bruni E; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Riether C; Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
  • Jacobsen EM; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
  • Jandus P; Department of Oncological Sciences, Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Conrad C; Cancer Center IRCCS Humanitas Research Hospital, Milan, Italy.
  • Hoenig M; Pediatric Department, University of Insubria, Varese, Italy.
  • Schulz A; Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Center, Rozzano-Milan, Italy.
  • Michaud K; Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Center, Rozzano-Milan, Italy.
  • Della Porta MG; Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy.
  • Salvatore S; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Ho PC; Department of Pediatrics, University Medical Center Ulm, Ulm, Germany.
  • Gfeller D; Division of Immunology and Allergology, Department of Medicine, University Hospital and Medical Faculty, Geneva, Switzerland.
  • Ochsenbein A; Department of Dermatology, University Hospital CHUV, Lausanne, Switzerland.
  • Mavilio D; Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
  • Curti A; Department of Pediatrics, University Medical Center Ulm, Ulm, Germany.
  • Marcenaro E; Department of Pediatrics, University Medical Center Ulm, Ulm, Germany.
  • Steinle A; University Center of Legal Medicine Lausanne-Geneva, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Horowitz A; Cancer Center IRCCS Humanitas Research Hospital, Milan, Italy.
  • Romero P; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Trabanelli S; Pediatric Department, University of Insubria, Varese, Italy.
  • Jandus C; Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
Blood Adv ; 3(22): 3674-3687, 2019 11 26.
Article en En | MEDLINE | ID: mdl-31765481
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Células Asesinas Naturales / Leucemia Mieloide Aguda / Subgrupos Linfocitarios / Antígeno CD56 / Inmunidad Innata Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Células Asesinas Naturales / Leucemia Mieloide Aguda / Subgrupos Linfocitarios / Antígeno CD56 / Inmunidad Innata Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article País de afiliación: Suiza